Brief: Guerbet Q3 Revenue Up At EUR 187 Mln
Oct 20 (Reuters) - GUERBET SA GRBT.PA :
* 2022 FINANCIAL OBJECTIVES UPDATE
* IMPACT OF THE PRIORITIZATION OF ELUCIREMTM PRODUCTION ON
THE
RALEIGH SITE
* 2022 OUTLOOK: REVENUE GROWTH OF LESS THAN 2% AT SCOPE AND
CER
* 2022 OUTLOOK: EBITDA MARGIN BETWEEN 13 AND 14%
* Q3 REVENUE: +5.1% AT CONSTANT EXCHANGE RATES (€187M)
Source text for Eikon: ID:nGNX9hhtKT
Further company coverage: GRBT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Guerbet SA
See all newsBrief: Guerbet Revenue At 30 September 2026 Of EUR 573.8 Million
Corrected: French medical imaging firm Guerbet's 9M revenue slips on China sales drop
French medical imaging firm Guerbet H1 EBITDA margin falls on Raleigh site costs
Brief: Guerbet H1 EBITDA €30.6 Mln
French and Benelux stocks-Factors to watch